EVERPAR ADVISORS LLC

Position in LLY — ELI LILLY & Co

CIK 2010410 TULSA, OK

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$3,334,415

+$871,271 QoQ

Shares Held

2,780

+3.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#2,034

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

EVERPAR ADVISORS LLC holds $12,411,314 across 10 Drug Manufacturers - General names. LLY ranks #1 (26.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,780	$3,334,415
2	JNJ	Johnson & Johnson	12,152	$3,086,243
3	ABBV	AbbVie Inc.	6,863	$1,727,005
4	MRK	Merck & Co., Inc.	9,417	$1,210,084
5	AMGN	Amgen Inc	2,218	$803,182
6	GILD	Gilead Sciences, Inc.	4,488	$567,013
7	AZN	Astrazeneca PLC	2,894	$548,760
8	BMY	Bristol Myers Squibb Co	8,874	$511,319

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,334,415	2,780	+3.8%	Shares	Sole	2026-07-09
2026-03-31	$2,463,144	2,678	-11.9%	Shares	Sole	2026-04-21
2025-12-31	$3,268,102	3,041	+11.0%	Shares	Sole	2026-01-07
2025-09-30	$2,090,620	2,740	+22.3%	Shares	Sole	2025-10-17
2025-06-30	$1,746,926	2,241	-10.4%	Shares	Sole	2025-07-08
2025-03-31	$2,066,426	2,502	-6.6%	Shares	Sole	2025-04-16
2024-12-31	$2,068,960	2,680	+0.6%	Shares	Sole	2025-01-15
2024-09-30	$2,359,258	2,663	-2.7%	Shares	Sole	2024-10-07
2024-06-30	$2,478,930	2,738	+7.2%	Shares	Sole	2024-07-18
2024-03-31	$1,986,131	2,553	-19.3%	Shares	Sole	2024-04-22
2023-12-31	$1,844,941	3,165	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.